Overview

The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke

Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
In this clinical study, the efficacy and safety of ALbumin is to be evaluated for the patients occurred within 12 hours of acute ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul St. Mary's Hospital
Collaborator:
Green Cross Corporation